Measurement of Conversion Coefficients in Normal and Triaxial Strongly Deformed Bands in <sup>167</sup>Lu
نویسندگان
چکیده
منابع مشابه
Measurement of Conversion Coefficients in Normal and Triaxial Strongly Deformed Bands in 167Lu
Internal conversion coefficients have been measured for transitions in both normal deformed and triaxial strongly deformed bands in 167 Lu using the Gammasphere and ICE Ball spectrometers. The results for all in-band transitions are consistent with E2 multipolarity. Upper limits are determined for the internal conversion coefficients for linking transitions between TSD Band 2 and TSD Band 1, th...
متن کاملQuadrupole Moment Measurements of TSD1 and TSD2 Bands in <sup>167</sup>Lu
The triaxial strongly deformed (TSD) bands in 167Lu were populated by the 123Sb(48Ca, 4n) reaction with a beam energy of 203 MeV. Gamma rays, requiring five fold or more in prompt coincidence, were detected with the Gammasphere spectrometer. Of particular interests are TSD bands 1 and 2 which have previously been interpreted as zero phonon and one phonon wobbling bands, respectively. Using the ...
متن کاملDosimetric analysis for the selection of radionuclides in bone pain palliation targeted therapy: A Monte Carlo simulation
Introduction:The use of beta emitters is one of the effective methods for palliation of bone metastasis. The risk of normal tissue toxicity should be evaluated in the bone pain palliation treatment. Methods: In this study, the Monte Carlo simulation code MCNPX was used for simulation a bone phantom model consisted of bone marrow, bone and soft tissue. Spe...
متن کاملPreparation and biodistribution assessment of low specific activity 177Lu-DOTATOC for optimization studies
Introduction: Somatostatin receptors expressed on a wide range of human tumors, are potential targets for the peptide receptor radionuclide therapy (PRRT). In this study, 177Lu-[DOTA-DPhe1, Tyr3]octreotide (177Lu-DOTATOC) as an agent for PRRT was prepared and its biodistribution was studied in rats. Methods:The ...
متن کاملRadiolabeling and evaluation of two 177Lu-labeled bis-phosphonates
Introduction: Bone pain palliation therapy is a mandate in handling end-stage cancer patients. The development of new ligands with higher stability, better pharmacokinetics and lower unwanted tissue uptakes (liver and GI) is still ongoing. Methods: In this work Lu-177 labeled (3-amino-1-hydroxypropane-1,1-di-yl)-bis-(phosphonate) (177Lu-pamidronate; 177Lu-PAM ), ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2017